°è¸í´ëÇб³ µ¿»êº´¿ø »õº´¿ø °³¿ø±â³ä °£´ãµµÃéÀå¾Ï ¹× °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2019-06-29±³À°ÀÏÀÚ : 2019-06-29
±³À°Àå¼Ò : °è¸í´ëÇб³ µ¿»êº´¿ø, 5Ãþ ¼¼¹Ì³ª½Ç1
±³À°ÁÖÁ¦ :
°è¸í´ëÇб³ µ¿»êº´¿ø »õº´¿ø °³¿ø±â³ä °£´ãµµÃéÀå¾Ï ¹× °£ÀÌ½Ä ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
´ã´çÀÚ : À̺¸¹Ì
¿¬¶ôó : 02-2051-8299
À̸ÞÀÏ :
khbps@khbp.or.kr ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 9 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 09:10~09:30 New biomarkers to detect very early stage HCC À庴±¹(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 09:30~09:50 Application of proton beam therapy for advanced HCC ±èÅÂÇö(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 09:50~10:10 The changing landscape of systemic treatment in HCC Richard S. Finn(UCLA, USA)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 10:10~10:30 RFA vs anatomical resection vs liver transplantation for the single small HCC °±¸Á¤(°è¸íÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 10:30~10:45 Discussion ±èÈ«¼ö(¼øõÇâÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 10:30~10:45 Discussion Ź¿ø¿µ(°æºÏÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 10:30~10:45 Discussion ±èâ¿í(°¡Å縯ÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 10:30~10:45 Discussion ±è¼ºÈÆ(±¹¸³¾Ï¼¾ÅÍ)
ÈÞ½Ä 06-29 10:45~11:00 Coffee break ()
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 11:00~11:20 Pathologic and molecular characteristics of pancreatic cancer °À¯³ª(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 11:20~11:40 Neoadjuvant and adjuvant chemotherapy for pancreatic cancer ±èÁø¿µ(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 11:40~12:00 What ÀÌÇöÁ÷(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 12:00~12:20 Result of radical surgery for the pancreatic cancer in DSMC ±è¿ëÈÆ(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 12:20~12:40 The long-term oncologic outcome of laparoscopic PD for the pancreatic cancer - data China Wen Hui Lou(Fudan Univ., China)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 12:40~12:55 Discussion ÀÌÅÂÈñ(°Ç¾çÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 12:40~12:55 Discussion ÇÑÁö¹Î(´ë±¸°¡Å縯ÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 12:40~12:55 Discussion °Ã¢¹«(¿¬¼¼ÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 12:40~12:55 Discussion ±è»ó°É(°æºÏÀÇ´ë)
½Ä»ç 06-29 12:55~14:00 Lunch & hospital tour ()
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 14:00~14:20 Molecular features of cholangiocarcinoma ¾È±Ù¼ö(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 14:20~14:40 Preoperative biliary drainage for the extrahepatic bile duct carcinoma Á¶±¤¹ü(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 14:40~15:00 Result of chemo-radiation therapy after surgical resection for the advanced cholangiocarcinoma ±èÁøÈñ(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 15:00~15:20 Our recent results of vascular reconstruction for advanced hilar cholangiocarcinoma Satoshi Hirano(Hokkaido Univ., Japan)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 15:20~15:35 Discussion ³ë¿µÈÆ(µ¿¾ÆÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 15:20~15:35 Discussion Á¶À翵(¼¿ïÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 15:20~15:35 Discussion ±è±¹Çö(¿µ³²ÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 15:20~15:35 Discussion Á¤¹Î±Ô(°æºÏÀÇ´ë)
ÈÞ½Ä 06-29 15:35~15:50 Coffee break ()
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 15:50~16:10 Extended indication criteria of liver transplantation: AMC experience Ȳ½Å(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 16:10~16:30 The experience of liver transplantation in DSMC ±èż®(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 16:30~16:50 Donor hepatectomy: hydrid to totally laparoscopic hepatectomy À¯¿µ°æ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 16:50~17:10 The challenges to overcome issues in LDLT at Kyushu University Toru Ikegami(Kyushu Univ., Japan)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 17:10~17:25 Discussion ÃÖµ¿¶ô(´ë±¸°¡Å縯ÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 17:10~17:25 Discussion ÇÑ¿µ¼®(°æºÏÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 17:10~17:25 Discussion ±èÁ¾¸¸(¼º±Õ°üÀÇ´ë)
Åä·Ð 06-29 5Ãþ ¼¼¹Ì³ª½Ç1 17:10~17:25 Discussion ½Åµ¿Çö(¼º±Õ°üÀÇ´ë)